Form SCHEDULE 13G/A SAB Biotherapeutics, Filed by: Woodline Partners LP
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| (NASDAQ: SABS) | Delayed: 3.04 +0.22 (7.80%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.82 | 52 Week High | $ | |||
| Open | $2.83 | 52 Week Low | $ | |||
| Day High | $3.08 | P/E | N/A | |||
| Day Low | $2.83 | EPS | $ | |||
| Volume | 710,205 | |||||
